IGF2 and breast cancer: Further Sciacca et al., 1999, provided evidence for an autocrine IR/IGF-II signalling pathway in breast cancer cells, including TNBC cell lines, where the IR-A isoform binds IGF-II with an affinity close to that of insulin [12].